Alleging that a leading cancer funder is slashing their support in an “unethical and reckless” way, six prominent cancer researchers at the University of California, San Diego (UCSD), have filed a lawsuit to compel it to continue its current level of support. The suit, filed quietly in November 2019 and amended last week, contends that the Ludwig Institute for Cancer Research (LICR) is gradually drawing down its funding for cancer prevention and treatment research to the six plaintiffs, in order to close its 29-year-old San Diego branch by 2023.

In a statement, LIRC confirmed it is winding down the San Diego branch—but stressed that, “[i]n implementing this decision, the Ludwig Institute is honoring its contractual obligations.” LICR also said it plans to respond to the lawsuit’s specific allegations “in due course.”


Editorial Team
Author: Editorial Team